GLG Pharma is a private, clinical-stage biotechnology company delivering therapies for hyper-proliferative diseases such as cancer (breast, ovarian, glioblastoma), polycystic kidney disease, psoriasis, Crohn’s disease and inflammatory bowel disease. They have a tested and proven approach to culturing cancer cells that helps identify the best technologies, diagnostics, and drug candidates whether small molecule or large biomolecules.
Their website 2 lists some of their products and services along with their prices. They offer products such as Transformed Breast Media (Ince BMI-T), Primary Ovarian Cancer Establishment Media (Ince OCMI-e), Primary T-Cell Leukemia Media (Ince TLMI) and more. The price of each product is $579 for 500 ml.
Location: United States, Florida
Member count: 1-10
Phone: +1 781-883-6639
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | Florida In... | florida-in... |